Insulet (PODD) Net Cash Flow (2010 - 2026)
Insulet's (PODD) quarterly Net Cash Flow came in at -$233.8 million in Q1 2026, down 171.74% YoY from $325.9 million in Q1 2025, and down 456.67% on a QoQ basis from -$42.0 million in Q4 2025.
Insulet (PODD) Net Cash Flow (2010 - 2026) Analysis & Trends
Insulet (PODD) has 17 years of Net Cash Flow data on file, last reported at -$233.8 million in Q1 2026.
- Quarterly Net Cash Flow fell 171.74% year-over-year to -$233.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$808.4 million (down 251.84% YoY) and the FY2025 annual result came in at -$248.7 million, down 197.15% from the prior year.
- Net Cash Flow eased to -$233.8 million in Q1 2026, from -$42.0 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $325.9 million in Q1 2025 to a low of -$362.3 million in Q3 2025.
- A 5-year average of -$19.2 million and a median of $15.8 million in 2023 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2023 — Net Cash Flow surged 1238.89% — and 2025, when it plunged 569.91%.
- Tracing PODD's Net Cash Flow over 5 years: stood at -$52.2 million in 2022, then jumped by 130.27% to $15.8 million in 2023, then surged by 271.52% to $58.7 million in 2024, then tumbled by 171.55% to -$42.0 million in 2025, then sank by 456.67% to -$233.8 million in 2026.
- The last three Net Cash Flow figures came in at -$233.8 million (Q1 2026), -$42.0 million (Q4 2025), and -$362.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 527.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -892.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 458.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -8.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -183.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -926.40 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 45.10 Mn |
| 10 | Insulet | 10.18 Bn | 9.64 Bn | 562.60 Mn | 55.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 55.00 Mn |
| Jun 30, 2026 | 55.00 Mn |
| Mar 31, 2026 | -233.80 Mn |
| Mar 31, 2026 | -233.80 Mn |
| Dec 31, 2025 | -42.00 Mn |
| Dec 31, 2025 | -42.00 Mn |
| Sep 30, 2025 | -362.30 Mn |
| Sep 30, 2025 | -362.30 Mn |
| Jun 30, 2025 | -170.30 Mn |
| Jun 30, 2025 | -170.30 Mn |
| Mar 31, 2025 | 325.90 Mn |
| Mar 31, 2025 | 325.90 Mn |
| Dec 31, 2024 | 58.70 Mn |
| Dec 31, 2024 | 58.70 Mn |
| Sep 30, 2024 | 77.10 Mn |
| Sep 30, 2024 | 77.10 Mn |
| Jun 30, 2024 | 70.70 Mn |
| Jun 30, 2024 | 70.70 Mn |
| Mar 31, 2024 | 49.50 Mn |
| Mar 31, 2024 | 49.50 Mn |